Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Berger

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of Virology|October 10, 1998
Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from muMT/muMT miceD Homann, A Tishon, D P Berger, et al.
International Journal of Cancer|October 21, 1991
Induction of multiple-drug resistance during anti-neoplastic chemotherapy in vitroT Licht, H H Fiebig, K J Bross, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
The transjugular stent implantation for the treatment of malignant portal and hepatic vein obstruction in cancer patientsJ A Burger, A Ochs, K Wirth, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Tuberous sclerosis complex with end-stage renal failureH P Neumann, V Brüggen, D P Berger, et al.
The New England Journal of Medicine|November 18, 1993
Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau diseaseH P Neumann, D P Berger, G Sigmund, et al.
Cancer Research|November 1, 1992
Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative studyE Boven, B Winograd, D P Berger, et al.
Anticancer Research|May 1, 2001
Is there any correlation between MDR1, GST-pi-expression and CEA?C Weissenberger, H H Fiebig, J Lutterbach, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Expression of the proliferation-associated Ki-67 antigen of transferrin receptors and of DNA polymerase alpha in human tumour lines: implications for in vitro chemoresistanceT Licht, K J Bross, H H Fiebig, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1995
Cytotoxicity of TGF alpha-PE40 and correlation to expression of epidermal growth factor receptorD P Berger, L Herbstritt, U Hellerich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1994
Preclinical phase II studies in human tumor xenografts: a European multicenter follow-up studyS P Langdon, H R Hendriks, B J Braakhuis, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Virology|October 10, 1998
Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from muMT/muMT miceD Homann, A Tishon, D P Berger, et al.
International Journal of Cancer|October 21, 1991
Induction of multiple-drug resistance during anti-neoplastic chemotherapy in vitroT Licht, H H Fiebig, K J Bross, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
The transjugular stent implantation for the treatment of malignant portal and hepatic vein obstruction in cancer patientsJ A Burger, A Ochs, K Wirth, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Tuberous sclerosis complex with end-stage renal failureH P Neumann, V Brüggen, D P Berger, et al.
The New England Journal of Medicine|November 18, 1993
Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau diseaseH P Neumann, D P Berger, G Sigmund, et al.
Cancer Research|November 1, 1992
Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative studyE Boven, B Winograd, D P Berger, et al.
Anticancer Research|May 1, 2001
Is there any correlation between MDR1, GST-pi-expression and CEA?C Weissenberger, H H Fiebig, J Lutterbach, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Expression of the proliferation-associated Ki-67 antigen of transferrin receptors and of DNA polymerase alpha in human tumour lines: implications for in vitro chemoresistanceT Licht, K J Bross, H H Fiebig, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1995
Cytotoxicity of TGF alpha-PE40 and correlation to expression of epidermal growth factor receptorD P Berger, L Herbstritt, U Hellerich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1994
Preclinical phase II studies in human tumor xenografts: a European multicenter follow-up studyS P Langdon, H R Hendriks, B J Braakhuis, et al.
Pageof 4